Nexgel Inc (NXGL) Gross Profit Margin starting from the second quarter 2026 to second quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Nexgel Inc   (NASDAQ: NXGL)


Nexgel Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NXGL Gross Profit Margin (Jun 30 2026)
Q2 		(Mar 31 2026)
Q1 		(Dec 31 2025)
Q4 		(Sep 30 2025)
Q3 		(Jun 30 2025)
Q2
Y / Y Revenue Change 63.24 %
Seq. Revenue Change 78.85 %
Revenue In Millions $3.69
Gross Profit Margin 30.09 %
Gross Profit Margin Total Ranking # 1655
Gross Profit In Millions $1.11
Y / Y Gross Profit Change -11.84 %
Seq. Gross Profit Change 4.52 %


Commenting Second Quarter 2026 Gross Profit Margin
Nexgel Inc has managed to improve its Revenue sequentially to $3.69 millions by 78.85 % faster than Gross Profit increase of 4.52 % to $1.11 millions, this led to contraction in Gross Profit Margin to 30.09 %, but the Nexgel Inc II. Quarter Gross Profit Margin remained above company average rate of 29.43%.


Observing second quarter 2026 results within Medical Equipment & Supplies industry 117 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 1655, from total ranking in the previous quarter at 3093.
Learn about Gross Margin
NXGL's Gross Profit Margin second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 118
Healthcare Sector # 303
Overall # 1643

Gross Profit Margin Statistics
High Average Low
56.18 % 29.43 % 0.96 %
(Sep 30 2024)   (Jun 30 2021)


NXGL Gross Income Trends • More of NXGL's Profitabilty Ratios • NXGL Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
NXGL's Cumulative Gross Profit Margin
Medical Equipment & Supplies Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
NXGL's Gross Profit Margin Profitability versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for NXGL's Competitors
Gross Profit Margin Profit Margin for Nexgel Inc 's Suppliers
Gross Profit Margin Profit Margin for NXGL's Customers

You may also want to know
NXGL's Annual Growth Rates NXGL's Profitability Ratios NXGL's Asset Turnover Ratio NXGL's Dividend Growth
NXGL's Roe NXGL's Valuation Ratios NXGL's Financial Strength Ratios NXGL's Gross Profit Growth
NXGL's Roa NXGL's Inventory Turnover Ratio NXGL's Growth Rates NXGL's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Gross Profit MarginJun 30 2026 MRQ Gross ProfitJun 30 2026 MRQ Revenue
Vycor Medical Inc   82.35 %$ 0.344  Millions$ 0.418  Millions
Avita Medical Inc   81.87 %$ 17.767  Millions$ 21.702  Millions
Glaukos Corp  81.67 %$ 151.594  Millions$ 185.610  Millions
Si bone inc   79.54 %$ 44.548  Millions$ 56.010  Millions
Vaso Corporation  79.46 %$ 8.889  Millions$ 11.187  Millions
Electromed Inc   78.71 %$ 15.284  Millions$ 19.417  Millions
Treace Medical Concepts Inc   78.47 %$ 35.607  Millions$ 45.376  Millions
Profound Medical Corp   78.41 %$ 1.947  Millions$ 2.483  Millions
Pulmonx Corporation  77.97 %$ 17.742  Millions$ 22.756  Millions
Novocure Limited  77.61 %$ 142.478  Millions$ 183.584  Millions
Edwards Lifesciences Corporation  77.46 %$ 1,348.600  Millions$ 1,741.000  Millions
Atricure Inc   77.23 %$ 118.629  Millions$ 153.604  Millions
Anteris Technologies Global Corp   76.91 %$ 0.776  Millions$ 1.009  Millions
Carlsmed Inc   76.78 %$ 14.542  Millions$ 18.940  Millions
Rxsight Inc   76.72 %$ 25.886  Millions$ 33.741  Millions
Tactile Systems Technology Inc   76.25 %$ 65.349  Millions$ 85.698  Millions
Sanuwave Health Inc   76.23 %$ 7.424  Millions$ 9.739  Millions
Nuwellis Inc   76.08 %$ 1.498  Millions$ 1.969  Millions
Staar Surgical Co  74.55 %$ 69.727  Millions$ 93.535  Millions
Orthopediatrics Corp  74.27 %$ 52.366  Millions$ 70.508  Millions
Iradimed Corporation  74.07 %$ 15.160  Millions$ 20.466  Millions
Cytosorbents Corporation  73.18 %$ 7.049  Millions$ 9.633  Millions
Nexalin Technology Inc   73.16 %$ 0.009  Millions$ 0.012  Millions
Myomo Inc   73.07 %$ 8.852  Millions$ 12.114  Millions
Irhythm Holdings Inc   72.80 %$ 163.205  Millions$ 224.172  Millions
Co diagnostics Inc   72.73 %$ 0.121  Millions$ 0.166  Millions
Axogen inc   72.67 %$ 50.674  Millions$ 69.731  Millions
Omada Health Inc   72.62 %$ 63.787  Millions$ 87.835  Millions
Tela Bio Inc   72.28 %$ 13.943  Millions$ 19.291  Millions
Alphatec Holdings Inc   72.17 %$ 154.098  Millions$ 213.513  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.